ECSP23019850A - GLP-1/GIP DUAL AGONISTS - Google Patents
GLP-1/GIP DUAL AGONISTSInfo
- Publication number
- ECSP23019850A ECSP23019850A ECSENADI202319850A ECDI202319850A ECSP23019850A EC SP23019850 A ECSP23019850 A EC SP23019850A EC SENADI202319850 A ECSENADI202319850 A EC SENADI202319850A EC DI202319850 A ECDI202319850 A EC DI202319850A EC SP23019850 A ECSP23019850 A EC SP23019850A
- Authority
- EC
- Ecuador
- Prior art keywords
- glp
- dual agonists
- gip
- obesity
- gip dual
- Prior art date
Links
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Abstract
La presente invención se refiere a polipéptidos duales de acción prolongada agonistas del péptido 1 similar al glucagón y del polipéptido insulinotrópico dependiente de glucosa (GIP) humano que pueden usarse para tratar la diabetes mellitus tipo 2 (T2D), la diabetes con obesidad, la obesidad y la hiperlipidemia.The present invention relates to dual long-acting agonist glucagon-like peptide 1 and human glucose-dependent insulinotropic polypeptide (GIP) polypeptides that can be used to treat type 2 diabetes mellitus (T2D), diabetes with obesity, obesity and hyperlipidemia.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN202021045240 | 2020-10-17 |
Publications (1)
Publication Number | Publication Date |
---|---|
ECSP23019850A true ECSP23019850A (en) | 2023-05-31 |
Family
ID=85131249
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ECSENADI202319850A ECSP23019850A (en) | 2020-10-17 | 2023-03-21 | GLP-1/GIP DUAL AGONISTS |
Country Status (2)
Country | Link |
---|---|
AR (1) | AR123791A1 (en) |
EC (1) | ECSP23019850A (en) |
-
2021
- 2021-10-14 AR ARP210102841A patent/AR123791A1/en unknown
-
2023
- 2023-03-21 EC ECSENADI202319850A patent/ECSP23019850A/en unknown
Also Published As
Publication number | Publication date |
---|---|
AR123791A1 (en) | 2023-01-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO2023001960A2 (en) | dual glp-1/gip agonists | |
CL2022003654A1 (en) | Long-acting glp-1/gip dual agonists | |
ECSP17043648A (en) | GIP AND GLP-1 CO-AGONIST COMPOUNDS | |
MY197569A (en) | Gip/glp1 co-agonist compounds | |
CL2021003419A1 (en) | Glucagon-like peptide-1 receptor agonists | |
BRPI0924307A8 (en) | OXINTOMODULIN ANALOGS | |
AR064032A1 (en) | THERAPEUTIC USES OF HETEROLOGICAL POLYPEPTIDES IL-17A / F | |
AR099977A1 (en) | DOUBLE PEPTIDE AGONISTS OF THE RECIPIENTS OF THE SIMILAR PEPTIDE TO GLUCAGON 1 (GLP-1) AND OF THE GLUCAGON RECEIVER (GCG), DERIVED FROM EXENDINA-4 | |
CL2011003173A1 (en) | Glucagon analog, gip and glp-1 agonist; dimer comprising the glucagon analog; conjugated to the analog; composition comprising said analog; use to prepare a medicine to treat diabetes, reduce weight gain, or induce weight loss. | |
EP2070946A3 (en) | Invention affecting GLP-1 and Exendin | |
MX2021005725A (en) | Treatment of obesity and its complications. | |
EA202191379A1 (en) | COMBINED NAFLD AND NASH TREATMENT | |
ECSP23019850A (en) | GLP-1/GIP DUAL AGONISTS | |
BR112023024968A2 (en) | TREATMENT OF OBESITY AND OBESITY-RELATED DISORDERS | |
WO2023111278A3 (en) | Peptides triple agonists of gip, glp-1 and glp-2 | |
MX2015009433A (en) | Novel polypeptides having satiety hormone releasing activity. | |
RU2015129010A (en) | Derived insulinotropic peptide with a modified N-terminal charge | |
TH172514A (en) | Compounds work together GIP and GLP-1. |